0001104659-24-100328.txt : 20240916 0001104659-24-100328.hdr.sgml : 20240916 20240916205204 ACCESSION NUMBER: 0001104659-24-100328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240912 FILED AS OF DATE: 20240916 DATE AS OF CHANGE: 20240916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oliveira Orlando CENTRAL INDEX KEY: 0001699305 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42270 FILM NUMBER: 241302339 MAIL ADDRESS: STREET 1: 1000 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zenas BioPharma, Inc. CENTRAL INDEX KEY: 0001953926 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER ST, SUITE 1200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-271-2954 MAIL ADDRESS: STREET 1: 1000 WINTER ST, SUITE 1200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Zenas BioPharma (Cayman) Ltd DATE OF NAME CHANGE: 20221108 4 1 tm2424157-8_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-09-12 0 0001953926 Zenas BioPharma, Inc. ZBIO 0001699305 Oliveira Orlando C/O ZENAS BIOPHARMA, INC. 1000 WINTER ST., SUITE 1200 WALTHAM MA 02451 0 1 0 0 Chief Commercial Officer 0 Stock Option (Right to Buy) 17.00 2024-09-12 4 A 0 410000 0 A 2034-09-11 Common Stock 410000 410000 D The option vests as to 25% of the underlying shares of common stock on July 1, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service. By: /s/ Chase Jayasekera, Attorney-in-Fact 2024-09-16